Operating
Other Noncash Income (Expense)
Biogen Other Noncash Income (Expense) decreased by 47.4% to -$28M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 317.9%, from -$6.7M to -$28M. Over 4 years (FY 2021 to FY 2025), Other Noncash Income (Expense) shows an upward trend with a -23.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
Metric ID:
operating_other_noncash_income_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$44.3M | -$60.4M | -$37.7M | -$43.3M | -$68.9M | -$35.6M | -$60.4M | -$31.4M | -$29.1M | -$38.1M | -$49.6M | -$25.4M | -$39.6M | -$30.1M | -$64.5M | -$6.7M | -$9.3M | -$33.3M | -$19M | -$28M |
| QoQ Change | — | -36.3% | +37.6% | -14.9% | -59.1% | +48.3% | -69.7% | +48.0% | +7.3% | -30.9% | -30.2% | +48.8% | -55.9% | +24.0% | -114.3% | +89.6% | -38.8% | -258.1% | +42.9% | -47.4% |
| YoY Change | — | — | — | — | -55.5% | +41.1% | -60.2% | +27.5% | +57.8% | -7.0% | +17.9% | +19.1% | -36.1% | +21.0% | -30.0% | +73.6% | +76.5% | -10.6% | +70.5% | -317.9% |
Range-$68.9M – -$6.7M
CAGR-9.2%
Avg YoY Growth-7.0%
Median YoY Growth+18.5%
Other Noncash Income (Expense) at Other Companies
Frequently Asked Questions
- What is Biogen's other noncash income (expense)?
- Biogen (BIIB) reported other noncash income (expense) of -$28M in Q1 2026.
- How has Biogen's other noncash income (expense) changed year-over-year?
- Biogen's other noncash income (expense) decreased by 317.9% year-over-year, from -$6.7M to -$28M.
- What is the long-term trend for Biogen's other noncash income (expense)?
- Over 4 years (2021 to 2025), Biogen's other noncash income (expense) has grown at a -23.8% compound annual growth rate (CAGR), from -$202.2M to -$68.3M.